Literature DB >> 34261450

Genomic surveillance of antimicrobial resistant bacterial colonisation and infection in intensive care patients.

Kelly L Wyres1, Jane Hawkey2, Mirianne Mirčeta3, Louise M Judd2, Ryan R Wick2, Claire L Gorrie4, Nigel F Pratt5, Jill S Garlick5, Kerrie M Watson5, David V Pilcher6,7, Steve A McGloughlin6,7, Iain J Abbott8, Nenad Macesic2,8, Denis W Spelman8, Adam W J Jenney9,10, Kathryn E Holt2,11.   

Abstract

BACKGROUND: Third-generation cephalosporin-resistant Gram-negatives (3GCR-GN) and vancomycin-resistant enterococci (VRE) are common causes of multi-drug resistant healthcare-associated infections, for which gut colonisation is considered a prerequisite. However, there remains a key knowledge gap about colonisation and infection dynamics in high-risk settings such as the intensive care unit (ICU), thus hampering infection prevention efforts.
METHODS: We performed a three-month prospective genomic survey of infecting and gut-colonising 3GCR-GN and VRE among patients admitted to an Australian ICU. Bacteria were isolated from rectal swabs (n = 287 and n = 103 patients ≤2 and > 2 days from admission, respectively) and diagnostic clinical specimens between Dec 2013 and March 2014. Isolates were subjected to Illumina whole-genome sequencing (n = 127 3GCR-GN, n = 41 VRE). Multi-locus sequence types (STs) and antimicrobial resistance determinants were identified from de novo assemblies. Twenty-three isolates were selected for sequencing on the Oxford Nanopore MinION device to generate completed reference genomes (one for each ST isolated from ≥2 patients). Single nucleotide variants (SNVs) were identified by read mapping and variant calling against these references.
RESULTS: Among 287 patients screened on admission, 17.4 and 8.4% were colonised by 3GCR-GN and VRE, respectively. Escherichia coli was the most common species (n = 36 episodes, 58.1%) and the most common cause of 3GCR-GN infection. Only two VRE infections were identified. The rate of infection among patients colonised with E. coli was low, but higher than those who were not colonised on admission (n = 2/33, 6% vs n = 4/254, 2%, respectively, p = 0.3). While few patients were colonised with 3GCR- Klebsiella pneumoniae or Pseudomonas aeruginosa on admission (n = 4), all such patients developed infections with the colonising strain. Genomic analyses revealed 10 putative nosocomial transmission clusters (≤20 SNVs for 3GCR-GN, ≤3 SNVs for VRE): four VRE, six 3GCR-GN, with epidemiologically linked clusters accounting for 21 and 6% of episodes, respectively (OR 4.3, p = 0.02).
CONCLUSIONS: 3GCR-E. coli and VRE were the most common gut colonisers. E. coli was the most common cause of 3GCR-GN infection, but other 3GCR-GN species showed greater risk for infection in colonised patients. Larger studies are warranted to elucidate the relative risks of different colonisers and guide the use of screening in ICU infection control.
© 2021. The Author(s).

Entities:  

Keywords:  Antimicrobial resistance (AMR); Colonisation; Genomic surveillance; Intensive care; Transmission

Year:  2021        PMID: 34261450     DOI: 10.1186/s12879-021-06386-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  22 in total

1.  Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia.

Authors:  Robyn S Lee; Benjamin P Howden; M Lindsay Grayson; Norelle L Sherry; Claire L Gorrie; Jason C Kwong; Rhonda L Stuart; Tony M Korman; Caroline Marshall; Charlie Higgs; Hiu Tat Chan; Maryza Graham; Paul D R Johnson; Marcel J Leroi; Caroline Reed; Michael J Richards; Monica A Slavin; Leon J Worth
Journal:  Infect Control Hosp Epidemiol       Date:  2020-11-26       Impact factor: 3.254

2.  Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.

Authors:  Euihan Jung; Sookjin Byun; Hojin Lee; Sang Yi Moon; Hyuck Lee
Journal:  Am J Infect Control       Date:  2014-10       Impact factor: 2.918

3.  Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection.

Authors:  Daniel E Freedberg; Margaret J Zhou; Margot E Cohen; Medini K Annavajhala; Sabrina Khan; Dagmara I Moscoso; Christian Brooks; Susan Whittier; David H Chong; Anne-Catrin Uhlemann; Julian A Abrams
Journal:  Intensive Care Med       Date:  2018-06-23       Impact factor: 17.440

4.  Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  Keyvan Razazi; Armand Mekontso Dessap; Guillaume Carteaux; Chloé Jansen; Jean-Winoc Decousser; Nicolas de Prost; Christian Brun-Buisson
Journal:  Ann Intensive Care       Date:  2017-06-12       Impact factor: 6.925

5.  Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients.

Authors:  Claire L Gorrie; Mirjana Mirceta; Ryan R Wick; David J Edwards; Nicholas R Thomson; Richard A Strugnell; Nigel F Pratt; Jill S Garlick; Kerri M Watson; David V Pilcher; Steve A McGloughlin; Denis W Spelman; Adam W J Jenney; Kathryn E Holt
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

6.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Authors:  Alessandro Cassini; Liselotte Diaz Högberg; Diamantis Plachouras; Annalisa Quattrocchi; Ana Hoxha; Gunnar Skov Simonsen; Mélanie Colomb-Cotinat; Mirjam E Kretzschmar; Brecht Devleesschauwer; Michele Cecchini; Driss Ait Ouakrim; Tiago Cravo Oliveira; Marc J Struelens; Carl Suetens; Dominique L Monnet
Journal:  Lancet Infect Dis       Date:  2018-11-05       Impact factor: 25.071

7.  The prevalence of healthcare associated infections among adult inpatients at nineteen large Australian acute-care public hospitals: a point prevalence survey.

Authors:  Philip L Russo; Andrew J Stewardson; Allen C Cheng; Tracey Bucknall; Brett G Mitchell
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-15       Impact factor: 4.887

8.  Extended spectrum beta-lactamase producing Enterobacterales faecal carriage in a medical intensive care unit: low rates of cross-transmission and infection.

Authors:  Renaud Prevel; Alexandre Boyer; Fatima M'Zali; Thibaut Cockenpot; Agnes Lasheras; Véronique Dubois; Didier Gruson
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-10       Impact factor: 4.887

9.  Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.

Authors:  Alessandro Cassini; Diamantis Plachouras; Tim Eckmanns; Muna Abu Sin; Hans-Peter Blank; Tanja Ducomble; Sebastian Haller; Thomas Harder; Anja Klingeberg; Madlen Sixtensson; Edward Velasco; Bettina Weiß; Piotr Kramarz; Dominique L Monnet; Mirjam E Kretzschmar; Carl Suetens
Journal:  PLoS Med       Date:  2016-10-18       Impact factor: 11.069

10.  The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.

Authors:  Tanya Gurieva; Mirjam J D Dautzenberg; Marek Gniadkowski; Lennie P G Derde; Marc J M Bonten; Martin C J Bootsma
Journal:  Clin Infect Dis       Date:  2018-02-01       Impact factor: 9.079

View more
  4 in total

1.  Recovery of small plasmid sequences via Oxford Nanopore sequencing.

Authors:  Ryan R Wick; Louise M Judd; Kelly L Wyres; Kathryn E Holt
Journal:  Microb Genom       Date:  2021-08

2.  Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria.

Authors:  Sam Lipworth; Karina-Doris Vihta; Tim Davies; Sarah Wright; Merline Tabirao; Kevin Chau; Alison Vaughan; James Kavanagh; Leanne Barker; Sophie George; Shelley Segal; Stephane Paulus; Lucinda Barrett; Sarah Oakley; Katie Jeffery; Lisa Butcher; Tim Peto; Derrick Crook; Sarah Walker; Seilesh Kadambari; Nicole Stoesser
Journal:  Commun Med (Lond)       Date:  2022-08-11

3.  ESBL plasmids in Klebsiella pneumoniae: diversity, transmission and contribution to infection burden in the hospital setting.

Authors:  Jane Hawkey; Kelly L Wyres; Louise M Judd; Taylor Harshegyi; Luke Blakeway; Ryan R Wick; Adam W J Jenney; Kathryn E Holt
Journal:  Genome Med       Date:  2022-08-23       Impact factor: 15.266

4.  To kill or to be killed: pangenome analysis of Escherichia coli strains reveals a tailocin specific for pandemic ST131.

Authors:  Erwin Tantoso; Birgit Eisenhaber; Miles Kirsch; Vladimir Shitov; Zhiya Zhao; Frank Eisenhaber
Journal:  BMC Biol       Date:  2022-06-16       Impact factor: 7.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.